Back
CEL-SCI Vs. Protalix BioTherapeutics Industry Stock Comparison
Sell
20
CVM
CEL-SCI
Last Price:
$0.29
Seasonality Move:
20.56%
Sell
33
PLX
Protalix BioTherapeutics
Last Price:
$2.18
Seasonality Move:
1.71%
Sell
33
Protalix BioTherapeutics (PLX)
is a Sell
Is Protalix BioTherapeutics a Buy, Sell or Hold?
-
The current Protalix BioTherapeutics [PLX] share price is $2.24. The Score for PLX is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
-
PLX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PLX Stock Price Chart
What is Protalix BioTherapeutics's stock price today?
-
The Protalix BioTherapeutics share price today is $2.24Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PLX is experiencing slight selling pressure.
CVM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.03 | Sell |
Relative Strength Index (14 RSI): | 36.51 | Sell |
Chaikin Money Flow: | -865864 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.32 - 0.42) | Sell |
Bollinger Bands (100): | (0.37 - 0.77) | Sell |
PLX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 38.84 | Sell |
Chaikin Money Flow: | -223875 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.32 - 2.6) | Sell |
Bollinger Bands (100): | (1.37 - 2.39) | Buy |
CVM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.33 | Sell |
20-day SMA: | 0.37 | Sell |
50-day SMA: | 0.41 | Sell |
200-day SMA: | 0.88 | Sell |
8-day EMA: | 0.33 | Sell |
20-day EMA: | 0.36 | Sell |
50-day EMA: | 0.43 | Sell |
200-day EMA: | 0.88 | Sell |
PLX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.32 | Sell |
20-day SMA: | 2.43 | Sell |
50-day SMA: | 2.32 | Sell |
200-day SMA: | 1.48 | Buy |
8-day EMA: | 2.32 | Sell |
20-day EMA: | 2.37 | Sell |
50-day EMA: | 2.26 | Sell |
200-day EMA: | 1.72 | Buy |
CEL-SCI Earnings Growth & CVM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.25 per share, and a decrease next year of $0.00 per share.
Protalix BioTherapeutics Earnings Growth & PLX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
CEL-SCI Technical Analysis
Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Protalix BioTherapeutics Technical Analysis
Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |